Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 479

1.

Clinical features of early-stage possible Behçet's disease patients with a variant-type major organ involvement in Japan.

Suzuki T, Horita N, Takeuchi M, Ishido T, Mizuki Y, Mizuki R, Kawagoe T, Shibuya E, Yuta K, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Ishigatsubo Y, Kurosawa M, Takeno M, Kaneko T, Mizuki N.

Mod Rheumatol. 2019 Jul;29(4):640-646. doi: 10.1080/14397595.2018.1494501. Epub 2018 Nov 28.

PMID:
29954241
2.

The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behçet's disease.

Suwa A, Horita N, Ishido T, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Ishigatsubo Y, Kurosawa M, Kaneko T, Takeno M, Mizuki N.

Mod Rheumatol. 2019 Mar;29(2):357-362. doi: 10.1080/14397595.2018.1457424. Epub 2018 May 15.

PMID:
29583036
3.

Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.

Kamiyama R, Yoshimi R, Takeno M, Iribe Y, Tsukahara T, Kishimoto D, Kunishita Y, Sugiyama Y, Tsuchida N, Nakano H, Minegishi K, Tamura M, Asami Y, Kirino Y, Ishigatsubo Y, Ozato K, Nakajima H.

Mod Rheumatol. 2018 Nov;28(6):993-1003. doi: 10.1080/14397595.2018.1436028. Epub 2018 Feb 23.

PMID:
29385873
4.

Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.

Kirino Y, Kawaguchi Y, Tada Y, Tsukamoto H, Ota T, Iwamoto M, Takahashi H, Nagasawa K, Takei S, Horiuchi T, Ichida H, Minota S, Ueda A, Ohta A, Ishigatsubo Y.

Mod Rheumatol. 2018 Sep;28(5):858-864. doi: 10.1080/14397595.2017.1422231. Epub 2018 Jan 11.

PMID:
29278009
5.

Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.

Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N.

Rheumatology (Oxford). 2017 Nov 1;56(11):1918-1927. doi: 10.1093/rheumatology/kex285.

PMID:
28968732
6.

Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.

Ishido M, Horita N, Takeuchi M, Shibuya E, Yamane T, Kawagoe T, Ishido T, Minegishi K, Yoshimi R, Kirino Y, Hirohata S, Ishigatsubo Y, Takeno M, Kaneko T, Mizuki N.

Sci Rep. 2017 Aug 31;7(1):10196. doi: 10.1038/s41598-017-09938-z.

7.

Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility.

Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, Le J, Blake M, Erer B, Kawagoe T, Ustek D, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sousa I, Davatchi F, Francisco V, Shahram F, Abdollahi BS, Nadji A, Shafiee NM, Ghaderibarmi F, Ohno S, Ueda A, Ishigatsubo Y, Gadina M, Oliveira SA, Gül A, Kastner DL, Remmers EF.

Nat Genet. 2017 Mar;49(3):438-443. doi: 10.1038/ng.3786. Epub 2017 Feb 6.

8.

Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide Survey.

Ueda N, Ida H, Washio M, Miyahara H, Tokunaga S, Tanaka F, Takahashi H, Kusuhara K, Ohmura K, Nakayama M, Ohara O, Nishikomori R, Minota S, Takei S, Fujii T, Ishigatsubo Y, Tsukamoto H, Tahira T, Horiuchi T.

Arthritis Rheumatol. 2016 Nov;68(11):2760-2771. doi: 10.1002/art.39793.

9.

Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study.

Kirino Y, Ideguchi H, Takeno M, Suda A, Higashitani K, Kunishita Y, Takase-Minegishi K, Tamura M, Watanabe T, Asami Y, Uehara T, Yoshimi R, Yamazaki T, Sekiguchi A, Ihata A, Ohno S, Ueda A, Igarashi T, Nagaoka S, Ishigatsubo Y, Nakajima H.

Arthritis Res Ther. 2016 Oct 3;18(1):217.

10.

Non-IgG4-related Multifocal Fibrosclerosis.

Kunishita Y, Yoshimi R, Takeno M, Yamanaka S, Sugiyama Y, Tsuchida N, Kishimoto D, Kamiyama R, Minegishi K, Hama M, Kirino Y, Ishigatsubo Y, Ueda A, Nakajima H.

Intern Med. 2016;55(17):2497-502. doi: 10.2169/internalmedicine.55.6297. Epub 2016 Sep 1.

11.

On-demand ultrasonography assessment in the most symptomatic joint supports the 8-joint score system for management of rheumatoid arthritis patients.

Yoshimi R, Takeno M, Toyota Y, Tsuchida N, Sugiyama Y, Kunishita Y, Kishimoto D, Kamiyama R, Minegishi K, Hama M, Kirino Y, Ishigatsubo Y, Ohno S, Ueda A, Nakajima H.

Mod Rheumatol. 2017 Mar;27(2):257-265. doi: 10.1080/14397595.2016.1206173. Epub 2016 Jul 13.

PMID:
27409294
12.

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Hibi T, Hirohata S, Kikuchi H, Tateishi U, Sato N, Ozaki K, Kondo K, Ishigatsubo Y.

Medicine (Baltimore). 2016 Jun;95(24):e3863. doi: 10.1097/MD.0000000000003863. Erratum in: Medicine (Baltimore). 2016 Aug 07;95(31):e5074.

13.

Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.

Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y.

Leuk Lymphoma. 2017 Jan;58(1):104-109. Epub 2016 Jun 7.

PMID:
27267543
14.

Retrospective Study of Incidence and Prognostic Significance of Eosinophilia after Allogeneic Hematopoietic Stem Cell Transplantation: Influence of Corticosteroid Therapy.

Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H.

Turk J Haematol. 2016 Sep 5;33(3):196-201. doi: 10.4274/tjh.2015.0047. Epub 2016 Apr 18.

15.

Effect of adiponectin-encoding gene ADIPOQ single nucleotide polymorphisms +45 and +276 on serum lipid levels after antiretroviral therapy in Japanese patients with HIV-1-infection.

Kato H, Ohata A, Samukawa S, Ueda A, Ishigatsubo Y.

J Int Med Res. 2016 Apr;44(2):297-306. doi: 10.1177/0300060515621444. Epub 2016 Feb 1.

16.

Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.

Yamamoto W, Fujii E, Matsumoto K, Yamamoto E, Aoki J, Tanaka M, Ishigatsubo Y, Kanamori H.

Int J Hematol. 2016 Apr;103(4):444-52. doi: 10.1007/s12185-016-1941-2. Epub 2016 Jan 20.

PMID:
26791379
17.

Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study.

Yamanaka H, Nagaoka S, Lee SK, Bae SC, Kasama T, Kobayashi H, Nishioka Y, Ueki Y, Seto Y, Nishinarita M, Tamura N, Kimura N, Saito K, Tomita T, Nawata Y, Suzuki S, Ishigatsubo Y, Munakata Y, Makino Y, Inoue E, Tanaka Y, Takeuchi T; ENCOURAGE study group.

Mod Rheumatol. 2016 Sep;26(5):651-61. doi: 10.3109/14397595.2015.1123349. Epub 2015 Dec 23.

PMID:
26698929
18.

The effectiveness of sputum pH analysis in the prediction of response to therapy in patients with pulmonary tuberculosis.

Masuda M, Sato T, Sakamaki K, Kudo M, Kaneko T, Ishigatsubo Y.

PeerJ. 2015 Nov 26;3:e1448. doi: 10.7717/peerj.1448. eCollection 2015.

19.

Chronic Use of Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-analysis.

Horita N, Miyazawa N, Kojima R, Inoue M, Ishigatsubo Y, Kaneko T.

Arch Bronconeumol. 2016 May;52(5):233-8. doi: 10.1016/j.arbres.2015.02.021. Epub 2015 Nov 21. Review. English, Spanish.

20.

An Autopsy Case Report of Malignant Pleural Mesothelioma with Deciduoid Features.

Ushio R, Yamamoto M, Shibata Y, Ishii H, Watanabe K, Takahashi R, Sato T, Kudo M, Miyake A, Kaneko T, Ishigatsubo Y.

Intern Med. 2015;54(22):2915-7. doi: 10.2169/internalmedicine.54.4940. Epub 2015 Nov 15.

21.

Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure.

Tachibana T, Yamamoto E, Kawasaki R, Koharazawa H, Ishibashi D, Nakajima Y, Tanaka M, Matsumoto K, Ishigatsubo Y, Fujisawa S.

Intern Med. 2015;54(21):2749-52. doi: 10.2169/internalmedicine.54.4809. Epub 2015 Nov 1.

22.

HO-1 inhibits IL-13-induced goblet cell hyperplasia associated with CLCA1 suppression in normal human bronchial epithelial cells.

Mishina K, Shinkai M, Shimokawaji T, Nagashima A, Hashimoto Y, Inoue Y, Inayama Y, Rubin BK, Ishigatsubo Y, Kaneko T.

Int Immunopharmacol. 2015 Dec;29(2):448-453. doi: 10.1016/j.intimp.2015.10.016. Epub 2015 Oct 24.

PMID:
26507166
23.

Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behçet's disease.

Arimoto J, Endo H, Kato T, Umezawa S, Fuyuki A, Uchiyama S, Higurashi T, Ohkubo H, Nonaka T, Takeno M, Ishigatsubo Y, Sakai E, Matsuhashi N, Nakajima A.

Dig Endosc. 2016 Mar;28(2):179-85. doi: 10.1111/den.12552. Epub 2015 Oct 28.

PMID:
26459917
24.

Currently Used Low-Dose Pyrazinamide Does Not Increase Liver-Injury in the First Two Months of Tuberculosis Treatment.

Horita N, Miyazawa N, Yoshiyama T, Kojima R, Ishigatsubo Y, Kaneko T.

Intern Med. 2015;54(18):2315-20. doi: 10.2169/internalmedicine.54.5533. Epub 2015 Sep 15.

25.

Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy.

Miyashita K, Tomita N, Taguri M, Suzuki T, Ishiyama Y, Ishii Y, Nakajima Y, Numata A, Hattori Y, Yamamoto W, Miyazaki T, Tachibana T, Takasaki H, Matsumoto K, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y.

Leuk Res. 2015 Aug 29. pii: S0145-2126(15)30368-4. doi: 10.1016/j.leukres.2015.08.016. [Epub ahead of print]

PMID:
26350140
26.

Brain FDG-PET reflecting clinical course of depression induced by systemic lupus erythematosus: Two case reports.

Saito T, Hama M, Chiba Y, Katsuse O, Kamada A, Ikura T, Minegishi K, Ihata A, Takahashi Y, Ishigatsubo Y, Hirayasu Y.

J Neurol Sci. 2015 Nov 15;358(1-2):464-6. doi: 10.1016/j.jns.2015.08.015. Epub 2015 Aug 12. No abstract available.

PMID:
26318204
27.

Impact of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis.

Horita N, Hashimoto S, Miyazawa N, Fujita H, Kojima R, Inoue M, Ueda A, Ishigatsubo YI, Kaneko T.

Intern Med. 2015;54(12):1473-9. Review.

28.

Monocyte nadir is a possible indicator for neutrophil nadir during lung cancer chemotherapy.

Moriyama Y, Horita N, Kudo M, Shinkai M, Fujita H, Yamanaka T, Ishigatsubo Y, Kaneko T.

Clin Respir J. 2017 Jul;11(4):453-458. doi: 10.1111/crj.12358. Epub 2015 Sep 17.

PMID:
26260239
29.

Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.

Tomita N, Taguri M, Hashimoto C, Takasaki H, Fujimaki K, Motomura S, Koharazawa H, Takemura S, Fujita H, Yamazaki E, Kawasaki R, Taguchi J, Sakai R, Fujisawa S, Hattori Y, Kanamori H, Yamamoto W, Harano H, Ogawa K, Ishigatsubo Y.

Ann Hematol. 2015 Nov;94(11):1935-7. doi: 10.1007/s00277-015-2448-2. Epub 2015 Jul 25. No abstract available.

PMID:
26208667
30.

Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors.

Sato T, Shimosato T, Ueda A, Ishigatsubo Y, Klinman DM.

Mol Cancer Ther. 2015 Oct;14(10):2198-205. doi: 10.1158/1535-7163.MCT-15-0401. Epub 2015 Jul 23.

31.

Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia.

Tachibana T, Tanaka M, Hagihara M, Kawasaki R, Yamazaki E, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H.

Int J Hematol. 2015 Oct;102(4):451-9. doi: 10.1007/s12185-015-1836-7. Epub 2015 Jul 15.

PMID:
26173594
32.

(18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.

Watanabe T, Takase-Minegishi K, Ihata A, Kunishita Y, Kishimoto D, Kamiyama R, Hama M, Yoshimi R, Kirino Y, Asami Y, Suda A, Ohno S, Tateishi U, Ueda A, Takeno M, Ishigatsubo Y.

Mod Rheumatol. 2016;26(2):180-7. doi: 10.3109/14397595.2015.1069458. Epub 2015 Aug 3.

PMID:
26140472
33.

Post-treatment PET-CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass.

Takasaki H, Yamamoto W, Ishii Y, Takahashi H, Watanabe R, Harada T, Kawasaki R, Hashimoto C, Motomura S, Tomita N, Ishigatsubo Y, Sakai R.

Indian J Hematol Blood Transfus. 2015 Sep;31(3):346-51. doi: 10.1007/s12288-014-0479-9. Epub 2014 Dec 3.

34.

Deep-inspiration breath-hold 18F-FDG-PET/CT is useful for assessment of connective tissue disease associated interstitial pneumonia.

Uehara T, Takeno M, Hama M, Yoshimi R, Suda A, Ihata A, Ueda A, Tateishi U, Ishigatsubo Y.

Mod Rheumatol. 2016;26(1):121-7. doi: 10.3109/14397595.2015.1054099. Epub 2015 Sep 18.

PMID:
25995034
35.

[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy].

Koharazawa H, Watanabe R, Hattori Y, Numata A, Kawasaki R, Kuwabara H, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Taguchi J, Tomita N, Fujita H, Sakai R, Harano H, Ishigatsubo Y, Fujisawa S.

Rinsho Ketsueki. 2015 Apr;56(4):392-9. doi: 10.11406/rinketsu.56.392. Japanese.

PMID:
25971269
36.

Adalimumab in the management of Behçet's disease.

Ueda A, Takeno M, Ishigatsubo Y.

Ther Clin Risk Manag. 2015 Apr 13;11:611-9. doi: 10.2147/TCRM.S56163. eCollection 2015. Review.

37.

R-CHOP therapy alone for limited-stage follicular lymphoma.

Tomita N, Suzuki T, Ishiyama Y, Miyashita K, Takahashi H, Numata A, Ito S, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Yamazaki E, Taguchi J, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y.

Leuk Res. 2015 Jun;39(6):582-5. doi: 10.1016/j.leukres.2015.03.008. Epub 2015 Apr 6.

PMID:
25866096
38.

Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation.

Numata A, Kajiyama R, Itabashi M, Ishii Y, Yamamoto W, Motohashi K, Matsumoto K, Hagihara M, Ishigatsubo Y, Fujisawa S.

Leuk Lymphoma. 2016;57(1):201-2. doi: 10.3109/10428194.2015.1037763. Epub 2015 May 12. No abstract available.

PMID:
25860242
39.

Predicting joint destruction in rheumatoid arthritis with power Doppler, anti-citrullinated peptide antibody, and joint swelling.

Kirino Y, Hama M, Takase-Minegishi K, Kunishita Y, Kishimoto D, Yoshimi R, Asami Y, Ihata A, Oba MS, Tsunoda S, Ohno S, Ueda A, Takeno M, Ishigatsubo Y.

Mod Rheumatol. 2015;25(6):842-8. doi: 10.3109/14397595.2015.1026025. Epub 2015 Apr 30.

PMID:
25736364
40.

Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Ishii Y, Tomita N, Suzuki T, Ishiyama Y, Kishimoto K, Yamamoto E, Koyama S, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Takemura S, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y.

Leuk Lymphoma. 2015;56(9):2750-2. doi: 10.3109/10428194.2015.1010161. Epub 2015 Mar 6. No abstract available.

PMID:
25644745
41.

Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease.

Hirohata S, Kikuchi H, Sawada T, Nagafuchi H, Kuwana M, Takeno M, Ishigatsubo Y.

J Neurol Sci. 2015 Feb 15;349(1-2):143-8. doi: 10.1016/j.jns.2015.01.005. Epub 2015 Jan 10.

PMID:
25601769
42.

Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.

Nakajima Y, Tomita N, Itabashi M, Miyashita K, Watanabe R, Miyazaki T, Tachibana T, Takasaki H, Kawasaki R, Tanaka M, Hashimoto C, Yamazaki E, Taguchi J, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Harano H, Motomura S, Ishigatsubo Y.

Leuk Res. 2015 Feb;39(2):198-203. doi: 10.1016/j.leukres.2014.11.030. Epub 2014 Dec 8.

PMID:
25541027
43.

Vitamin D binding protein genotype variants and risk of chronic obstructive pulmonary disease: a meta-analysis.

Horita N, Miyazawa N, Tomaru K, Inoue M, Ishigatsubo Y, Kaneko T.

Respirology. 2015 Feb;20(2):219-25. doi: 10.1111/resp.12448. Epub 2014 Dec 9. Review.

44.

Successful pregnancy and delivery via in vitro fertilization with cryopreserved and thawed embryo transfer in an acute myeloid leukemia patient after allogeneic bone marrow transplantation.

Nakajima Y, Kuwabara H, Kishimoto K, Numata A, Motohashi K, Tachibana T, Tanaka M, Yamashita N, Ishigatsubo Y, Fujisawa S.

Int J Hematol. 2015 Apr;101(4):417-20. doi: 10.1007/s12185-014-1709-5. Epub 2014 Nov 28.

PMID:
25430084
45.

Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium.

Yamamoto E, Tomita N, Ishigatsubo Y.

Br J Haematol. 2015 Feb;168(4):469. doi: 10.1111/bjh.13212. Epub 2014 Nov 17. No abstract available.

PMID:
25403768
46.

A novel 8-joint ultrasound score is useful in daily practice for rheumatoid arthritis.

Yoshimi R, Ihata A, Kunishita Y, Kishimoto D, Kamiyama R, Minegishi K, Hama M, Kirino Y, Asami Y, Ohno S, Ueda A, Takeno M, Ishigatsubo Y.

Mod Rheumatol. 2015 May;25(3):379-85. doi: 10.3109/14397595.2014.974305. Epub 2014 Nov 17.

PMID:
25401228
47.

Post-therapy ¹⁸F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma.

Tomita N, Hattori Y, Fujisawa S, Hashimoto C, Taguchi J, Takasaki H, Sakai R, Tateishi U, Ishigatsubo Y.

Ann Hematol. 2015 Mar;94(3):431-6. doi: 10.1007/s00277-014-2227-5. Epub 2014 Oct 23.

PMID:
25338967
48.

Measurement of eNO with portable analyser might improve the management of persistent cough at primary care practice in Japan.

Watanabe K, Shinkai M, Shinoda M, Hara Y, Yamaguchi N, Rubin BK, Ishigatsubo Y, Kaneko T.

Clin Respir J. 2016 May;10(3):380-8. doi: 10.1111/crj.12228. Epub 2014 Nov 26.

PMID:
25307553
49.

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease.

Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T.

Clin Gastroenterol Hepatol. 2015 May;13(5):940-8.e3. doi: 10.1016/j.cgh.2014.08.042. Epub 2014 Sep 19.

50.

Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapy.

Nakajima Y, Tomita N, Watanabe R, Ishiyama Y, Yamamoto E, Ishibashi D, Itabashi M, Koyama S, Takahashi H, Numata A, Takasaki H, Kawasaki R, Kuwabara H, Tanaka M, Hashimoto C, Fujimaki K, Sakai R, Motomura S, Ishigatsubo Y.

Med Oncol. 2014 Sep;31(9):185. doi: 10.1007/s12032-014-0185-3. Epub 2014 Aug 21.

PMID:
25142947

Supplemental Content

Loading ...
Support Center